Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Meibao Biotechnology is a leading Chinese manufacturer of in vitro diagnostic reagents and rapid test kits. Its product portfolio includes fertility tests such as pregnancy and ovulation kits as well as infectious disease diagnostics for HIV, hepatitis B/C, syphilis, malaria, dengue fever, COVID‑19 antigen/antibody testing and more. The company holds CE marking and ISO13485 certification. Products are sold both domestically in China and internationally across Europe, Asia-Pacific, Africa and other regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Meibao Biotechnology.